NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
Medicine and Neuroscience exploratory research grant from National Institutes of Health
Apply by Friday, Oct 16
Closes in 6 days
About
NIH PA-25-304 supports exploratory biomedical, behavioral and clinical research at an early conceptual stage, including risky approaches, new methods and models. Clinical trials are not permitted. Projects must fit a participating NIH institute or center. The next new-application deadline is October 16, 2026 at 5 p.m. in the applicant organization’s local time; the next resubmission deadline is November 16. Direct costs are limited to USD 275,000 over two years and USD 200,000 in any one year. Apply through ASSIST, Grants.gov Workspace or an institutional system; organizational registrations and PI eRA Commons/ORCID records must be complete. Foreign subawards or subcontracts are prohibited under this notice, even though foreign organizations may apply.
Eligibility
Career stage: Not stated
Institution applies
Covers: Up to USD 275,000 in direct costs over at most two years, with no more than USD 200,000 in one year. No cost sharing required. Clinical trials and foreign subawards/subcontracts are excluded.
Host location: Worldwide
Domestic and foreign applicant organizations are eligible. Monetary foreign subawards/subcontracts are not permitted under this notice; funded international collaborations require a designated NOFO. Unfunded collaborations, foreign components, foreign consultants and procurement remain subject to NIH rules.
Reviewed Sep 25, 2026. Check the funder’s full conditions before applying.
Eligible domestic and foreign organizations include higher education institutions, nonprofits, businesses and the government/community entity categories listed in the notice. PIs must have the skills, resources and knowledge to perform the work and apply with an eligible organization.
Topics
Related funding
- Closes Jan 7, 2028National Institutes of Health
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Closes in 6 daysNational Institutes of HealthNeuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Closes in 6 daysNational Institutes of Health
More from National Institutes of Health
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Closes Oct 20National Institutes of HealthNIDA Animal Genomics Program (U01 – Clinical Trial Not Allowed)
Closes Feb 11, 2027National Institutes of HealthBRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
Closes Jun 15, 2027National Institutes of Health
Open funding in Medicine
All fundingMRFF 2026 Clinical Trials Activity Grant Opportunity (GO8645)
Closes Mar 10, 2027Medical Research Future Fund; administered by NHMRCNHMRC Centres of Research Excellence 2027
Closes in 4 daysNHMRCTargeted Call for Elite Researcher Grant 2026
Closes Nov 6NSW Health, Office for Health and Medical ResearchCentres of Excellence for Regulatory Science and Innovation
Closes Jan 12, 2027Medical Research Council (MRC)
Source: grants.nih.gov